These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16386014)

  • 1. Antibody-mediated protective immunity in fungal infections.
    Magliani W; Conti S; Arseni S; Salati A; Ravanetti L; Maffei DL; Giovati L; Polonelli L
    New Microbiol; 2005 Oct; 28(4):299-309. PubMed ID: 16386014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
    Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
    Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to fungal infections.
    Blanco JL; Garcia ME
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):47-70. PubMed ID: 18565595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.
    Polonelli L; Casadevall A; Han Y; Bernardis F; Kirkland TN; Matthews RC; Adriani D; Boccanera M; Burnie JP; Cassone A; Conti S; Cutler JE; Frazzi R; Gregory C; Hodgetts S; Illidge C; Magliani W; Rigg G; Santoni G
    Med Mycol; 2000; 38 Suppl 1():281-92. PubMed ID: 11204156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response to fungal infections.
    Shoham S; Levitz SM
    Br J Haematol; 2005 Jun; 129(5):569-82. PubMed ID: 15916679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventative and therapeutic vaccines for fungal infections: from concept to implementation.
    Deepe GS
    Expert Rev Vaccines; 2004 Dec; 3(6):701-9. PubMed ID: 15606355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel monoclonal antibody recognizing beta(1-3) glucans in intact cells of Candida and Cryptococcus.
    Kondori N; Edebo L; Mattsby-Baltzer I
    APMIS; 2008 Oct; 116(10):867-76. PubMed ID: 19132980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against fungal infections.
    Segal E
    Crit Rev Microbiol; 1987; 14(3):229-71. PubMed ID: 3556019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced humoral immunity and vaccination against major human fungal pathogens.
    Casadevall A; Feldmesser M; Pirofski LA
    Curr Opin Microbiol; 2002 Aug; 5(4):386-91. PubMed ID: 12160857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of immunity in fungal infections.
    Chute HL
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):601-2. PubMed ID: 1092228
    [No Abstract]   [Full Text] [Related]  

  • 11. Host defenses against cryptococcosis.
    Price MS; Perfect JR
    Immunol Invest; 2011; 40(7-8):786-808. PubMed ID: 21985306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?
    Casadevall A; Cassone A; Bistoni F; Cutler JE; Magliani W; Murphy JW; Polonelli L; Romani L
    Med Mycol; 1998; 36 Suppl 1():95-105. PubMed ID: 9988497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal heat-shock proteins in human disease.
    Burnie JP; Carter TL; Hodgetts SJ; Matthews RC
    FEMS Microbiol Rev; 2006 Jan; 30(1):53-88. PubMed ID: 16438680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis I: interactions of host cells and fungi.
    Clemons KV; Calich VL; Burger E; Filler SG; Grazziutti M; Murphy J; Roilides E; Campa A; Dias MR; Edwards JE; Fu Y; Fernandes-Bordignon G; Ibrahim A; Katsifa H; Lamaignere CG; Meloni-Bruneri LH; Rex J; Savary CA; Xidieh C
    Med Mycol; 2000; 38 Suppl 1():99-111. PubMed ID: 11204170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody immunity and invasive fungal infections.
    Casadevall A
    Infect Immun; 1995 Nov; 63(11):4211-8. PubMed ID: 7591049
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary defense mechanisms against opportunistic fungal pathogens.
    Waldorf AR
    Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recognition mechanism of pathogen-associated molecular patterns and role of innate immune lymphocytes in fungal infection].
    Kawakami K
    Rinsho Byori; 2009 Aug; 57(8):779-85. PubMed ID: 19764413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans).
    Ramirez-Ortiz ZG; Means TK
    Virulence; 2012 Nov; 3(7):635-46. PubMed ID: 23076328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective antibodies and endemic dimorphic fungi.
    Nosanchuk JD
    Curr Mol Med; 2005 Jun; 5(4):435-42. PubMed ID: 15977999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.
    Valadon P; Nussbaum G; Boyd LF; Margulies DH; Scharff MD
    J Mol Biol; 1996 Aug; 261(1):11-22. PubMed ID: 8760499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.